Ensuring Leadership Continuity—The Coleman Health Services Case Study is starting in

A Best Practice Approach to Developing & Managing an Injection Clinic: Changing Pharma Options Brings New Interest in Injectable Medications

OPEN MINDS The Behavioral Health & Social Service Industry Analyst Industry Special Injection clinics as a service delivery option for delivery of long-acting antipsychotic medications have been in operation since the introduction of the first generation antipsychotics in the 1960s (fluphenazine enanthate in 1963, fluphenazine decanoate in 1967, and haloperidol decanoate in 1986). First generation long-acting antipsychotic medications were specifically developed as maintenance treatment for patients with a history of nonadherence with oral antipsychotics. By simplifying the medication process—no more need to take pills every day—the ability to monitor medication adherence made treatment more manageable for . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.